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Abstract
Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been
attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic
diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal
growth.
Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound
parameters describing the newborn’s body shape as well as parameters describing the newborns endocrine system such as
cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets.
Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately.
Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy,
maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound
investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male
but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal
diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise
significantly correlated with paternal BMI in male newborns only.
Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor
for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring
sex specific paternal programming of cortisol secretion.
Citation: Chen Y-P, Xiao X-M, Li J, Reichetzeder C, Wang Z-N, et al. (2012) Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in
a Gender Dependent Manner. PLoS ONE 7(5): e36329. doi:10.1371/journal.pone.0036329
Editor: Qi Sun, Brigham and Women’s Hospital and Harvard Medical School, United States of America
Received December 31, 2011; Accepted April 3, 2012; Published May 3, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hocher@uni-potsdam.de
Introduction
Low birth weight is an independent risk factor for cardiovas-
cular disease and glucose intolerance in later life. This was first
elucidated in a study investigating thef the geographical distribu-
tion of heart disease in Great Britain [1]. Several epidemiological
studies in Europe, the United States and India have thereafter
confirmed these findings [2–8]. It was suggested that coronary
artery disease (CAD), glucose intolerance and hypertension arise
from mechanisms primarily related to factors originated in the
mother. In particular maternal malnutrition occurring during
critical time windows of development can lead to irreversible
morphological (for example: structural changes of the hypotha-
lamic nuclei, changes in size and number of islets in the endocrine
pancreas or changes of the nephron number in the kidney) and
functional changes (changes of blood pressure regulating endo-
crine systems like the renin-angiotensin-aldosteron system) and
a higher susceptibility to disease later in life (such as: hypertension,
chronic renal failure, metabolic syndrome, type 2 diabetes, stroke
and myocardial infarction) [9,10]. In the context of our study, it is
important to note that the low birth weight phenotype is associated
with higher central (abdominal) adipositas in later life.
Meanwhile other maternal mechanisms leading to an increased
risk of diabetes, renal diseases and cardiovascular diseases in later
life have been described such as maternal genes modifying
offspring physiology in early life without being transmitted to the
offspring [11,12] and factors affecting placenta function such as
placental 11 beta HSD activity [13,14]. Besides it is known that
maternal over nutrition/obesity induces fetal programming. For
example, a high protein diet offered to rat dams during pregnancy
and lactation causes gender specific effects in the offspring. Male
offspring is characterized by an elevated blood pressure, whereas
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36329female offspring gains more weight and has an increased energy
expenditure [15]. Maternal high-fat or cholesterol over-feeding
during pregnancy and lactation in rodents results in an offspring
phenotype that closely resembles the human metabolic syndrome
[16]. Phenotypic characteristics of the offspring in these rodent
models of fetal programming included an abnormal glucose
homeostasis [17,18], increased blood pressure, abnormal serum
lipid profiles and increased adiposity [19].
However, in very recent animal studies evidence emerged that
paternal factors may influence fetal growth (assessed by measuring
birth weight) and the risk of cardiovascular diseases in later life.
Especially paternal obesity may cause long-term effects on the
metabolism of the offspring. A recent study demonstrated that
a chronic high-fat diet in male rats programs b-cell dysfunction in
female rat offspring [20]. This study is in line with a study in
humans showing that paternal body fat is a long-term predictor of
changes in premenarch body fat of girls [21]. In this context it is of
interest that a recent animal study also reported paternal
transgenerational genetic effects besides the well-known epigenetic
effects on body weight and food intake [22]. In line with this study
is a human epidemiological study showing that paternal BMI (and
maternal BMI) is positively correlated with childhood BMI at age
of 11 and in adulthood [23]. However, little is known about fetal
growth during intrauterine life in relationship to paternal obesity
in humans. We thus analyzed the relationship between measures
of paternal BMI, as a surrogate of obesity, and birth weight as well
as ultrasound parameters describing the newborn’s body shape in
a Chinese birth cohort to test the hypothesis that paternal BMI
may be associated with fetal growth.
Methods
Clinic data collection
Participants from this study came from the Guangzhou birth
cohort [24]. The study was approved by the ethics committee of
Jinan University, Guangzhou, China. We obtained written
informed consent from all participants involved in our study.
We invited a total of 932 Chinese women who delivered their
babies at the obstetric department of the first affiliated hospital of
Jinan university between March 2010 to October 2010 to
participate in the study. Inclusion criteria were as follows: (1) the
newborn was born without congenital anomalies; (2) singleton
pregnancy; (3) no hepatitis B, C and D, no HIV and no syphilis.
After exclusion of cases that did not fulfill the inclusion criteria or
were not willing to participate, we finally included 889 remaining
cases. After obtaining written consent, a structured medical history
was taken. Chinese guidelines for medical follow-up in pregnancy
comprise a perinatal health manual which contains essential data
about the pregnancy. The data in the ‘Perinatal health manual’
were also used to judge whether the women fulfilled all inclusion
and exclusion criteria. The following data were extracted into our
database: nationality/ethnic background, age, body height, body
weight before and during pregnancy, gravidity, parity, gestational
age at delivery, smoking before/during pregnancy, and alcohol
consumption during pregnancy and blood pressure readings at all
follow-up visits. The criteria for diagnosis of pregnancy-induced
hypertension were based on the definition of the Chinese
hypertension society: systolic blood pressure of $140 mm Hg
and/or a diastolic blood pressure of $90 mm Hg after 20 weeks
gestation, measured at least at two occasions with a break of 4 to
6 hours in-between. Gestational age was calculated from the first
day of the last normal menstrual period and confirmed by either
first or early second trimester ultrasound scans. Biometric data of
the newborns were routinely measured immediately after delivery.
Sample collection and glycated serum protein (GSP)
assay
Fetal blood was collected from the umbilical cord (umbilical
vein) within 10 minutes after delivery. Midwives collected
maternal blood from a cubital vein in the delivery room or on
the ward before delivery immediately after the pregnant women
were hospitalized for giving birth. Mothers were asked to stop
eating when being hospitalized for giving birth. Food intake prior
to hospitalization was not recorded. Samples were processed
immediately. The resulting plasma samples were stored at 220uC
until analysis.
Total cortisol was measured by Fluorescence Polarization
Immunoassay (FPIA) (Abbott, USA, Catalog number 2G98 217-
232 6/05) on the AxSYM System (Abbott, USA), as performed
previously [25]. Glycated serum protein was measured as recently
described [24]. Plasma renin activity (PRA) and plasma aldoste-
rone were measured by radioimmunoassay (RIA; Beijing north
institute of biological technology, Beijing, China, CAT number:
D01PZB for PRA measurements (angiotensin I RIA, D03PZB for
aldosterone measurements), on a GC-1200c radioimmunoassay
counter (Anhui ustc zonkia scientific instruments co., LTD,
China). The PRA method is based on the analysis of the
generation of angiotensin I. For detail of the PRA method and
aldosterone, see: Chen YP, Li Y, Wang NZ, Reichetzeder, Xu H,
Gong J, Chen GJ, Pfab T, Xiao XM, Hocher B. Angiotensin
Aldosterone System and Glycemia in Pregnancy. Clin Laborartory
58(May–June); (2012), in press. All the blood samples were
measured by experienced technologists in a certified laboratory of
the hospital.
Ultrasound measurements during pregnancy
Ultrasound measurements during pregnancy were done as
described previously [24]. All the anthropometric parameters of
Table 1. Detailed descriptive data of the newborn’s mothers
and fathers (n=899).
Maternal age, years 28.4963.71
Hypertension before pregnancy, n (%) 5 (0.56%)
Hypertension during pregnancy, n (%) 39 (4.33%)
Gestational age at delivery, days 274.4469.79
Gravidity, n 1.7461.06
Parity, n 1.1960.45
Maternal height, cm 159.964.7
Maternal BMI before pregnancy, kg/m
2 20.262.4
Maternal weight before pregnancy, kg 51.766.9
Maternal weight at delivery, kg 67.668.3
Maternal cortisol, nmol/L 806.876333.34
Maternal aldosterone, ng/ml 0.28960.248
Maternal rennin activity, ng/ml/h 5.8763.97
Maternal glycated serum protein, mmol/L 117.88629.27
Maternal fasting glucose, mmol/L 4.7660.63
Paternal age, years 31.3664.62
Paternal height, cm 171.5465.25
Paternal weight, kg 68.5969.87
Paternal BMI, kg/m
2 23.2862.88
Data are given as mean 6 SD or absolute numbers.
doi:10.1371/journal.pone.0036329.t001
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ultrasound examination units with an integrated image analysis
software (MEDISON ACCUVIX V20, South Korea and GE
VOLUSON 730 EXPERT, USA). Only obstetric physicians that
passed the examination for ultrasound diagnostics during
pregnancy performed the analysis ensuring the quality of the
data. The biparietal diameter was measured from the outer edge
of the parietal bone near the probe to the inner edge of the other
side of the parietal bone at the cross-sectional plane of the fetal
brain with major land marks including the cavum septi pellucidi,
thalamus, third ventricle and ambient cistern. The head
circumference was measured in the same plane as the biparietal
diameter using the elliptic function of the ultrasound instrument.
Abdominal circumference was measured in a plane at the level of
the fetal umbilical plexus perpendicular to the spine including the
spine, stomach bubble, liver, umbilical vein, the skin and
subcutaneous fat. Femur length was measured using predefined
anatomic points that can easily be detected by ultrasound
techniques in a standartizised manner (from the greater trochanter
to the lateral condyle). Assessment of pectoral diameter and
abdominal diameter were also conducted using standard clinical
measurement protocols.
Data analysis
Data were analyzed with SPSS version 19.0. Results are
presented as mean 6 standard deviation. When examining the
correlation between paternal BMI with birth weight or ultrasound
parameters describing fetal growth, factors that are known to
influence intrauterine growth and showed a significant bivariate
correlation or association with birth weight or ultrasound
parameters in our cohort, respectively, were used as co-variables.
Multivariable regression analysis, see also references 24 and 25.
was used to adjust for confounding variables known to in-
dependently influence birth weight and intrauterine growth.
To ensure that the findings are robust, we tested the effect of
paternal BMI on fetal growth in different two-sided multivariable
regression models. Model A considered – besides maternal BMI –
maternal and paternal age, hypertension during pregnancy,
maternal glycated serum protein, parity and either gestational
age (for birth weight) or time of ultrasound investigation (for
ultrasound parameters) as confounding factors. Model B was
calculated excluding cases of paternal hypertension but consider-
ing maternal BMI, paternal and maternal age, hypertension
during pregnancy, maternal glycated serum protein, parity and
either gestational age (for birth weight) or time of ultrasound
investigation (for ultrasound parameters) as confounding factors.
Model C considered maternal BMI, hypertension during preg-
nancy, maternal glycated serum protein and either gestational age
(for birth weight) or time of ultrasound investigation (for
ultrasound parameters) as confounding factors. A p-value of less
than 0.05 was considered significant.
Results
Description of the cohort
Demographic data describing the participating couples and
their offspring are given in table 1 and 2. We finally included 899
father/mother/child triplets with 492 newborn boys and 407
newborn girls, respectively. Participating fathers were slightly older
and had a higher body mass index as their female partners. The
mean age of the fathers was 31.36 years and their mean body mass
index was 23,28 kg/m
2, whereas the mean age of the mothers was
28.49 years and the mean BMI prior to pregnancy was 20.20 kg/
m
2.
Effects of paternal BMI on fetal growth
Since fetal programming is an offspring gender dependent
process [15], the analyses of the effect of maternal and paternal
BMI on fetal growth were performed separately for girls and boys.
Gestational age at delivery was 274.4469.79 days; the
ultrasound examination was done at gestational day
266.8615.1. We used these data to describe the newborns body
shape, since the birth process is known to affect certain
anthropometric parameters (e.g.: head circumference) immediate-
ly after birth [26].
When analyzing cases including male offpspring only, all tested
models revealed that paternal BMI correlated significantly with
birth weight, biparietal diameter, head circumference, abdominal
diameter, abdominal circumference and pectoral diameter
(Table 3).
However, when analyzing cases only including female offspring,
all tested models revealed that paternal BMI did not correlate with
birth weight, biparietal diameter, head circumference, abdominal
diameter, abdominal circumference and pectoral diameter
(Table 4). Key findings of the ultrasound examination are
illustrated in figure 1 and 2.
These analyses uniformely showed that the effect of paternal
BMI on birth weight as well on parameters describing offspring
intrauterine growth are highly dependent on offspring gender.
Effects of paternal BMI on fetal hormones
In order to detect effects of paternal BMI on the newborns
endocrine system, we measured renin activity, aldosterone-,
cortisol- and fetal glycated serum protein (as a parameter of
glycemic control) concentrations in fetal blood taken right after
delivery. Renin activity, aldosterone- and glycated serum protein
concentrations of newborn boys and girls in the fetal blood right
after delivery cortisol, aldosterone, renin activity and fetal glycated
serum protein (as a parameter of glycemic control). Aldosterone,
renin activity and glycemic control as analyzed by measuring fetal
glycated serum protein were not related to paternal BMI in
newborn boys and girls (data not shown). However, the
Table 2. Biometric data of the newborns (n=899) data of the
newborns (n=899).
Child birth weight, g 3260.56441.0
Gestational age at delivery, day 274.469.8
Child sex, male/female 492/407
Apgar score at 5 min 9.9460.28
Apgar score at 10 min 9.9860.14
Late ultrasound analysis time, day 266.8615.1
Late biparietal diameter, mm 93.865.0
Late head circumference, mm 329.1614.5
Late pectoral diameter, mm 90.167.4
Late abdominal diameter, mm 102.468.9
Late abdominal circumference, mm 336.2624.4
Late femur length, mm 70.464.2
Fetal cortisol, nmol/L 295.186210.71
Fetal aldosterone, ng/ml 0.38360.225
Fetal renin activity, ng/ml/h 7.02664.000
Fetal glycated serum protein, mmol/L 90.84620.515
Data are given as mean 6 SD or absolute numbers.
doi:10.1371/journal.pone.0036329.t002
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newborns, however, was was significantly associated with paternal
BMI in male offspring (Table 5). This association, as well as
associations with birth weight and ultrasound parameters de-
scribing fetal growth were not seen in female offspring (Table 5).
Discussion
The present study demonstrated that paternal BMI during
conception is associated with fetal growth of the male offspring but
not female offspring. This was shown by analyzing birth weight
and ultrasound parameter describing the body size of the newborn
prior to birth. In addition, we could demonstrate that fetal cortisol
at delivery is associated with paternal BMI in male offspring only.
Anthropometric parameters, especially head circumference, of
newborns may be influenced by labor [26]. Measurements of
anthropometric parameters were therefore obtained by ultrasound
examinations some days prior to birth. Thus these values are not
influenced by labor and hence are reliable. The cohort studied
here is representative in terms of key characteristics of a Chinese
cohort like maternal age, maternal height, maternal body mass
index before pregnancy, gestational age and birth weight [27,28]
suggesting that our findings are of general impact. In order to
demonstrate the robustness of our findings we used different
models to analyze the relationship between paternal BMI and
offspring growth. We could demonstrate that the results were
similar when analyzing all cases (all comers) or just cases without
any hint for an underlying paternal disease (Table 3 and 4). In
addition, also the more complex model considering maternal BMI,
paternal and maternal age, hypertension during pregnancy,
maternal glycated serum protein concentations, parity and either
gestational age (for birth weight) or time of ultrasound in-
vestigation (for ultrasound parameters) as confounding factors
basically came to similar findings as the simple model considering
maternal BMI, hypertension during pregnancy, maternal glycated
serum protein, and either gestational age (for birth weight) or time
of ultrasound investigation (for ultrasound parameters) as con-
founding factors (Tables 3 and 4): Paternal BMI during conception
is associated with growth of the male offspring only.
The fetal programming hypothesis suggests that environmental
factors in early life may alter the risk of cardiovascular diseases in
later life. It is thought that environmental factors like maternal
nutrition or maternal exposure to toxins like cigarette smoke lead
to epigenetic alterations of the offspring which influence the
activity of key cardiovascular regulatory systems like insulin
resistance, blood pressure and lipid metabolism in later life
[1,29]. Typically, mechanisms leading to fetal programming of
cardiovascular diseases in later life are originated from environ-
mental influences or insults on the mother like maternal under-
and over-nutrition, maternal stress, maternal exposure to toxins,
and maternal genes that alter placenta function [1]. The potential
roles of paternal environmental effects on offspring health,
however, are poorly understood so far.
Increasing evidence emerging mainly from animal experiments
indicates an important biological role of fathers in fetal pro-
gramming as well. Recent studies demonstrated that high-fat diet
in fathers programs b-cell dysfunction in female rat offspring via
epigenetic mechanisms [20]. Also pre-mating fasting of male mice
was reported to affect serum glucose levels in offspring [30]. There
are so far only few human epidemiological data supporting this
concept: It was shown that paternal body fat is a long-term
predictor of changes in premenarch body fat of girls. There are
also data linking paternal famine with a higher risk of obesity and
cardiovascular disease two generations later [31,32]. The primary
Table 3. Multivariable regression analysis of the association
between ultrasound measurements in late gestation or birth
weight and paternal BMI in newborn boys.
Model A Model B Model C
Birth weight T 2.495 2.419 2.775
B 19.535 19.690 21.381
P-Value 0.013 0.016 0.006
95%CI 4.126–34.945 3.661–35.719 6.215–36.547
Biparietal
diameter
T 3.393 2.775 5.492
B 0.247 0.246 0.272
P-Value 0.001 0.002 ,0.001
95%CI 0.104–0.391 0.095–0.397 0.130–0.414
Head
circumference
T 2.779 3.101 3.014
B 0.587 0.696 0.627
P-Value 0.006 0.002 0.003
95%CI 0.171–1.002 0.254–1.139 0.217–1.036
Abdominal
diameter
T 2.217 2.343 2.237
B 0.341 0.368 0.340
P-Value 0.027 0.020 0.026
95%CI 0.038–0.644 0.059–0.677 0.041–0.639
Abdominal
circumference
T 3.049 3.288 3.226
B 1.019 1.133 1.065
P-Value 0.003 0.001 0.001
95%CI 0.361–1.677 0.454–1.812 0.415–1.715
Pectoral
diameter
T 2.036 2.203 2.096
B 0.297 0.338 0.302
P-Value 0.043 0.028 0.037
95%CI 0.010–0.585 0.036–0.640 0.018–0.586
Femur length T 0.957 0.984 1.114
B 0.055 0.060 0.064
P-Value 0.339 0.326 0.266
95%CI 20.058–0.169 20.060–0.180 20.049–0.176
B: partial regression coefficient; 95% CI: 95% confidence interval for B; T:
standardized regression coefficient.
Different regression models showing the association between ultrasound
measurements in late gestation or birth weight and paternal BMI in newborn
boys. Shown are the T, B and P-values for paternal BMI. B: non-standardized
regression coefficient.
Model A: multivariable regression analyses was done in all cases considering
maternal BMI, paternal and maternal age, hypertension during pregnancy,
maternal glycated serum protein, parity and either gestational age (for birth
weight) or time of ultrasound investigation (for ultrasound parameters) as
confounding factors.
Model B: multivariable regression analyses was done excluding cases where
fathers had hypertension but considering maternal BMI, paternal and maternal
age, hypertension during pregnancy, maternal glycated serum protein, parity
and either gestational age (for birth weight) or time of ultrasound investigation
(for ultrasound parameters) as confounding factors.
Model C: multivariable regression analyses was done in all cases considering
maternal BMI, hypertension during pregnancy, maternal glycated serum
protein, and either gestational age (for birth weight) or time of ultrasound
investigation (for ultrasound parameters) as confounding factors.
doi:10.1371/journal.pone.0036329.t003
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paternal obesity at conception to offspring birth weight.
Independent groups worldwide demonstrated that both mater-
nal under-nutrition as well as maternal over-nutrition during
pregnancy lead to a gender specific phenotype in the offspring
[15,33–38].
A recent study also indicated that paternal obesity seems to
affect the offspring in a gender dependent manner [20].
Meanwhile, in various models of fetal programming it has
conclusively been shown that fetal programming processes affect
the offspring in a gender dependent manner. This was the
justification to separately analyze female and male offspring.
Figure 1. Biparietal diameter of male (A) and female (B) offspring in relationship to paternal BMI. Ultrasound examination was done in
average at gestational day 266.8. Black Bar: Paternal BMI below median; Hatched Bar: Paternal BMI above median. #: p=0.008 versus male offspring
of fathers with a BMI below the median of all paternal BMI data of the cohort; Data are given as mean +/2 SEM.
doi:10.1371/journal.pone.0036329.g001
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a sex-specific manner, we just start to get insights into the
underlying molecular mechanisms. The concept that environmen-
tal challenges such as nutrition challenges during pregnancy
trigger stable epigenetic DNA alterations in the offspring is widely
accepted providing the basis for our general understanding of
molecular pathways of fetal programming. There is evidence
showing that the gender dependency of fetal programming could
Figure 2. Abdominal diameter of male (A) and female (B) offspring in relationship to paternal BMI. Ultrasound examination was done in
average at gestational day 266.8. Black Bar: Paternal BMI below median; Hatched Bar: Paternal BMI above median. &: p=0.003 versus male offspring
of fathers with a BMI below the median of all paternal BMI data.
doi:10.1371/journal.pone.0036329.g002
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regulatory pathways underlying sexual development of most
organs and the lifelong fluctuating impact of sex hormones. The
expression of a substantial proportion of dimorphic genes is under
the control of sex-specific epigenetic marks. Environmental factors
such as nutrition or chemical compounds can influence – in
a gender-dependent manner – these epigenetic marks during
particular developmental windows of early intrauterine life. Thus,
these finely tuned mechanisms may sex dependently be more or
less sensitive to specific environmental challenges, particularly
during developmental programming and gametogenesis [39–42].
These gender dependent differences in the epigenetic response to
environmental factors like nutrition may cause for example
gender-specific alterations of key hormone systems for cardiovas-
cular diseases in the offspring such as the Renin-Angiotensin-
Aldosterone-System (to test this hypothesis we analyzed aldoste-
rone and renin activity in the fetal bood) or pituitary-adrenal axis
(for this reason we analyzed cortisol).
To the best of our knowledge, this is the first study showing that
paternal BMI during conception is associated with growth of the
male but not female offspring. The underlying mechanisms still are
unknown. Since we also saw a moderate association between
paternal BMI and fetal cortisol in newborn boys, paternal
programming of the hypothalamus-hypophyis-adrenal axis in
a gender dependent manner (see above) might be possible. It
was already shown that this endocrine system is subject to fetal
programming [43,44]. There is also evidence the the results seem
not to be influenced by the way of taking fetal blood [45].
Table 4. Multivariable regression analysis of the association between ultrasound measurements in late gestation or birth weight
and paternal BMI in newborn girls.
Model A Model B Model C
Birth weight T 0.914 0.825 1.219
B 6.779 6.262 8.970
P-Value 0.362 0.410 0.224
95%CI 27.829–21.387 28.689–21.213 25.529–23.469
Biparietal diameter T 1.652 1.836 1.795
B 0.125 0.139 0.134
P-Value 0.100 0.068 0.074
95%CI 20.024–0.273 20.010–0.288 20.013–0.280
Head circumference T 1.443 1.810 1.669
B 0.317 0.400 0.361
P-Value 0.150 0.072 0.096
95%CI 20.116–0.751 20.036–0.836 20.065–0.787
Abdominal diameter T 1.081 0.870 1.457
B 0.170 0.139 0.228
P-Value 0.281 0.385 0.146
95%CI 2.140–0.479 20.176–0.454 20.080–0.537
Abdominal circumference T 0.762 0.592 1.095
B 0.262 0.210 0.377
P-Value 0.447 0.554 0.275
95%CI 20.416–0.941 20.489–0.908 20.302–1.056
Pectoral diameter T 20.008 20.015 0.245
B 20.001 20.002 0.033
P-Value 0.994 0.988 0.807
95%CI 20.268–0.266 20.274–0.269 20.230–0.295
Femur length T 1.498 1.467 1.679
B 0.097 0.097 0.107
P-Value 0.136 0.144 0.094
95%CI 20.031–0.224 20.033–0.228 20.019–0.233
Different regression models showing the association between ultrasound measurements in late gestation or birth weight and paternal BMI in newborn girls. Shown are
the T, B and P-values for paternal BMI. B: non-standardized regression coefficient.
Model A: multivariable regression analyses was done in all cases considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal
glycated serum protein, parity and eithergestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding factors.
Model B: multivariable regression analyses was done excluding cases where fathers had hypertension but considering maternal BMI, paternal and maternal age,
hypertension during pregnancy, maternal glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound
parameters) as confounding factors.
Model C: multivariable regression analyses was done in all cases considering maternal BMI, hypertension during pregnancy, maternal glycated serum protein, and either
gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding factors.
B: partial regression coefficient; 95% CI: 95% confidence interval for B; T: standardized regression coefficient.
doi:10.1371/journal.pone.0036329.t004
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also considering vaginal versus cesarean section and the
occurrence of perinatal asphyxia besides the confounders included
in our statistical model (maternal BMI, paternal and maternal age,
gestational age, maternal hypertension during pregnancy and
gestational diabetes, see also table 5). Our study may stimulate
animal experiments aiming to explore the potential underlying
mechanisms of the association of paternal BMI and male offspring
intrauterine growth. It is meanwhile well established that fetal
programming occurs in a gender dependent manner [15]. This
was also shown in animal models of paternal programming. As
mentioned above, a high-fat diet in fathers programs b-cell
dysfunction in female rat offspring [20], whereas preconceptional
fasting of fathers alters serum glucose particularly in male offspring
of mice [30]. This study furthermore showed that in male offspring
of fasted fathers, there was a possible small effect on serum
corticosterone and serum IGF-1 levels. For female offspring,
serum corticosterone and IGF-1 levels were not altered by
preconceptional paternal fasting [30]. This also supports the
hypothesis that the hypothalamus-hypophyis-adrenal axis may be
subject to offspring gender specific paternal programming. Again,
this needs to be proven in adequately designed experimental
models.
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